Pentwater Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-27,500	Closed	-$1.99M	–	74
2013 Q3	$1.99M	Buy	+27,500	New	+$1.99M	0.05%	63